Five things to know:
1. Verb Surgical is focused on robotics and data science products. Combined with Johnson & Johnson, the company hopes to make medical interventions less invasive and more personalized.
2. Johnson & Johnson first purchased ownership in Verb Surgical in 2015, adding the technology to its digital surgery portfolio.
3. Johnson & Johnson’s digital surgery portfolio includes robotics, enhanced visualization, advanced instrumentation, machine learning and data analytics as well as end-to-end connectivity. The company aims to stay on the forefront of digital solutions for open surgery as well as laparoscopic and percutaneous procedures.
4. Earlier this year, Johnson & Johnson acquired Auris Health to launch its digital surgery strategy and introduced VELYS Digital Surgery in orthopedics earlier this month.
5. The companies expect to close the transaction during the first half of 2020 for an undisclosed amount.
More articles on orthopedic devices:
DePuy Synthes’ new partnership brings AI to orthopedics: 4 details
4 acquisitions that rocked the spine world in the 2010s — and where they are now
Moody’s: US medical device outlook positive — 7 expectations & headwinds
